Transcendent Capital Group LLC Myriad Genetics Inc Transaction History
Transcendent Capital Group LLC
- $195 Billion
- Q3 2024
A detailed history of Transcendent Capital Group LLC transactions in Myriad Genetics Inc stock. As of the latest transaction made, Transcendent Capital Group LLC holds 428 shares of MYGN stock, worth $7,631. This represents 0.01% of its overall portfolio holdings.
Number of Shares
428Holding current value
$7,631% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding MYGN
# of Institutions
240Shares Held
92.7MCall Options Held
117KPut Options Held
113K-
Black Rock Inc. New York, NY15.2MShares$270 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$179 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA8.26MShares$147 Million0.04% of portfolio
-
Camber Capital Management LP Boston, MA5.5MShares$98.1 Million3.72% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny4.4MShares$78.4 Million0.05% of portfolio
About MYRIAD GENETICS INC
- Ticker MYGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 80,634,800
- Market Cap $1.44B
- Description
- Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...